Jason M Uslaner Selected Research

Jason M Uslaner Research Topics

Disease

16	Schizophrenia (Dementia Praecox) 01/2023 - 03/2009
10	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 12/2011
5	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2020 - 01/2010
4	Cognitive Dysfunction 01/2020 - 04/2013
2	Psychotic Disorders (Schizoaffective Disorder) 02/2016 - 09/2014
2	Sleepiness 09/2014 - 11/2013
1	Mental Disorders (Mental Disorder) 02/2020
1	Tauopathies 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Chronic Pain 01/2018
1	Atrophy 01/2018
1	Memory Disorders (Memory Loss) 01/2015
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 09/2014
1	Cataplexy 01/2014
1	Narcolepsy 01/2014
1	AIDS-Related Complex (ARC) 04/2013
1	Tobacco Use Disorder (Nicotine Dependence) 10/2010
1	Neurobehavioral Manifestations 05/2010
1	Substance-Related Disorders (Drug Abuse) 10/2006
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2006

Drug/Important Bio-Agent (IBA)

6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2014 - 03/2009
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018 - 01/2013
4	Cholinergic Agents (Cholinergics)IBA 10/2021 - 12/2011
4	Orexin Receptor AntagonistsIBA 02/2020 - 01/2010
4	Donepezil (Aricept)FDA LinkGeneric 06/2015 - 12/2011
3	Glutamic Acid (Glutamate)FDA Link 01/2020 - 07/2014
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 01/2013
3	Antipsychotic Agents (Antipsychotics)IBA 07/2014 - 04/2010
2	metabotropic glutamate receptor 2IBA 01/2020 - 05/2010
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2016 - 01/2013
2	OrexinsIBA 09/2014 - 01/2013
2	DORA-22IBA 11/2013 - 04/2013
2	Zolpidem (Ambien)FDA LinkGeneric 11/2013 - 04/2013
2	Eszopiclone (Lunesta)FDA Link 11/2013 - 04/2013
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 03/2012 - 10/2010
1	compound 18IBA 01/2023
1	MK-8189IBA 01/2023
1	pyrimidineIBA 01/2023
1	suvorexantIBA 02/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	hexosaminidase CIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2018
1	thiamet GIBA 01/2018
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Liver X ReceptorsIBA 04/2016
1	Muscarinic M1 ReceptorIBA 01/2015
1	Scopolamine (Hyoscine)FDA Link 01/2015
1	GABA Receptors (GABA Receptor)IBA 09/2014
1	NeuropeptidesIBA 09/2014
1	5- methyl- N- (4- methylpyrimidin- 2- yl)- 4- (1H- pyrazol- 4- yl)thiazol- 2- amineIBA 09/2014
1	AminesIBA 09/2014
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 02/2014
1	Orexin ReceptorsIBA 01/2014
1	activity regulated cytoskeletal-associated proteinIBA 04/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 04/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2013
1	Ketamine FDA LinkGeneric 01/2013
1	gamma-Aminobutyric Acid (GABA)IBA 01/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2011
1	compound 20IBA 11/2010
1	Nicotine FDA Link 10/2010
1	EnzymesIBA 05/2010
1	3- cyano- N- (1,3- diphenyl- 1H- pyrazol- 5- yl)benzamideIBA 04/2010
1	Dizocilpine Maleate (Dizocilpine)IBA 04/2010
1	Clozapine (Clozaril)FDA LinkGeneric 04/2010
1	Metabotropic Glutamate 5 ReceptorIBA 04/2010
1	Sucrose (Saccharose)IBA 04/2010
1	Serine (L-Serine)FDA Link 04/2010
1	N-Methylaspartate (NMDA)IBA 03/2009

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2013
1	Behavior Control 10/2006